Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

Adjuvant chemotherapy after surgery is the standard treatment modality for stage III and part of stage II or stage IV colorectal cancer (CRC) patients. However, the 5-year overall survival (OS) rate remains unsatisfactory. Thus, developing combination therapies is essential to improve the prognosis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Pan, Qiu-Zhong, Zhao, Jing-Jing, Yang, Chao-Pin, Zhou, Yu-Qing, Lin, Jun-Zhong, Tang, Yan, Gu, Jia-Mei, Wang, Qi-Jing, Li, Yong-Qiang, He, Jia, Chen, Shi-Ping, Song, Meng-Jia, Huang, Yue, Yang, Jie-Ying, Weng, De-Sheng, Xia, Jian-Chuan
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185208/
https://ncbi.nlm.nih.gov/pubmed/32363125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1752563
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados